Joint (JYNT) Stock Overview
Operates and franchises chiropractic clinics in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for JYNT from our risk checks.
JYNT Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
The Joint Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.61 |
| 52 Week High | US$13.47 |
| 52 Week Low | US$9.58 |
| Beta | 1.53 |
| 1 Month Change | -7.42% |
| 3 Month Change | 6.10% |
| 1 Year Change | -7.42% |
| 3 Year Change | -44.16% |
| 5 Year Change | -42.18% |
| Change since IPO | 61.25% |
Recent News & Updates
Recent updates
The Joint Corp. Has Shown Good Momentum For Future Returns (Rating Upgrade)
Apr 29There's Reason For Concern Over The Joint Corp.'s (NASDAQ:JYNT) Price
Mar 20
The Joint Corp.'s (NASDAQ:JYNT) Intrinsic Value Is Potentially 59% Above Its Share Price
Jan 22The Joint Corp.'s (NASDAQ:JYNT) Price Is Out Of Tune With Revenues
Sep 14The Joint Corp. (NASDAQ:JYNT) Shares Could Be 22% Above Their Intrinsic Value Estimate
Aug 05Investors Could Be Concerned With Joint's (NASDAQ:JYNT) Returns On Capital
Jul 17Optimistic Investors Push The Joint Corp. (NASDAQ:JYNT) Shares Up 26% But Growth Is Lacking
May 04The Joint Corp.'s (NASDAQ:JYNT) Share Price Not Quite Adding Up
Mar 10Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
Feb 12Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue
Jun 17Joint's (NASDAQ:JYNT) Returns On Capital Are Heading Higher
Jan 04Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?
Oct 27The Joint Corp. Can Relieve You From High Inflation Pain
Oct 17The Joint Corp.: Weakening Bottom-Line Fundamentals Unsupportive In Current Landscape
Aug 05These 4 Measures Indicate That Joint (NASDAQ:JYNT) Is Using Debt Reasonably Well
Jul 22Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
Jun 29Is There Now An Opportunity In The Joint Corp. (NASDAQ:JYNT)?
Jun 14Shareholder Returns
| JYNT | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -2.6% | 2.0% | 0.5% |
| 1Y | -7.4% | -27.5% | 15.7% |
Return vs Industry: JYNT exceeded the US Healthcare industry which returned -27.5% over the past year.
Return vs Market: JYNT underperformed the US Market which returned 15.1% over the past year.
Price Volatility
| JYNT volatility | |
|---|---|
| JYNT Average Weekly Movement | 7.5% |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: JYNT has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: JYNT's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 590 | Sanjiv Razdan | www.thejoint.com |
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
The Joint Corp. Fundamentals Summary
| JYNT fundamental statistics | |
|---|---|
| Market cap | US$160.49m |
| Earnings (TTM) | -US$923.63k |
| Revenue (TTM) | US$53.45m |
Is JYNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JYNT income statement (TTM) | |
|---|---|
| Revenue | US$53.45m |
| Cost of Revenue | US$11.74m |
| Gross Profit | US$41.71m |
| Other Expenses | US$42.63m |
| Earnings | -US$923.63k |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.06 |
| Gross Margin | 78.03% |
| Net Profit Margin | -1.73% |
| Debt/Equity Ratio | 0% |
How did JYNT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/22 21:02 |
| End of Day Share Price | 2025/08/22 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
The Joint Corp. is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jeffrey Van Sinderen | B. Riley Securities, Inc. |
| Jeremy Hamblin | Craig-Hallum Capital Group LLC |
| Linda Bolton-Weiser | D.A. Davidson & Co. |